John William Wulf - 15 Mar 2023 Form 4 Insider Report for agilon health, inc. (AGL)

Role
Director
Signature
/s/ Steve Meetre, as Attorney-in-Fact
Issuer symbol
AGL
Transactions as of
15 Mar 2023
Net transactions value
-$1,545,224
Form type
4
Filing time
17 Mar 2023, 16:56:23 UTC
Previous filing
20 Apr 2022
Next filing
18 Apr 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AGL Common Stock Options Exercise $360,000 +80,000 +65% $4.50* 203,392 15 Mar 2023 Direct F1
transaction AGL Common Stock Sale $1,905,224 -80,000 -39% $23.82 123,392 15 Mar 2023 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AGL Options (Rights to Buy) Options Exercise $0 -80,000 -40% $0.000000 120,000 15 Mar 2023 Common Stock 80,000 $4.50 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes restricted stock units.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $23.68 to $23.98, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
F3 These options were granted on May 22, 2020, and vest on the first five anniversaries of the grant date, subject to continued service as a director.

Remarks:

Exhibit List: Ex.24 - Power of Attorney